Medable Stock

www.medable.comHealthcare / BioTech & PharmaFounded: 2012Funding to Date: $530.96MM

Medable is a cloud-based platform providing effective therapies to patients. The platform streamlines design, recruitment, retention and data quality for decentralized trials, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution.

Register To Buy and Sell Shares

For more details on financing and valuation for Medable, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Medable’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Medable.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About Medable’s Stock

Can you buy Medable’s stock?
Medable is not publicly traded on NYSE or NASDAQ in the U.S. To buy Medable’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Medable’s stock?
Yes, you can sell stock of a private company like Medable. Forge can help you sell your Medable stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Medable’s stock price?
Medable is a privately held company and therefore does not have a public stock price. However, you may access Medable’s private market stock price with Forge Data.
What is Medable’s stock ticker symbol?
Medable does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Medable Raises $304M Series D Funding at $2.1 Billion Valuation
Medable, a Palo Alto CA-based provider of a cloud platform for patient-centered clinical research, raised $304M in Series D funding at $2.1 Billion valuation
Medable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures and Tiger Global
Medable Inc., the leading cloud platform for patient-centered clinical research, today announced $304 million in Series D funding to accelerate global adoption of digital and decentralized clinical trials, enabling ubiquitous access to the latest treatments for every body and every biology. The funding round was co-led by new investors Blackstone Growth and Tiger Global and existing investor GSR Ventures. The round also includes follow-on investment from existing investors Sapphire Ventures and WTI.
Updated on: Apr 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.